FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a carrier applicable for the local drug delivery. A drug is enclosed in a carrier, and the carrier comprises a coating able to release an enclosed drug as a result of a local stimulus. The coating additionally surrounds the contrast agent MR 19F which changes its detectability after being released from the carrier. The invention refers to a method for the drug delivery to an MRT-controlled individual, wherein the method involves administering the above carrier into the individual enabling the carrier releasing the drug, and forming MR 19F images with the use of a contrast produced by the contrast agent MR 19F.
EFFECT: invention enables monitoring the beginning of the drug release from the carrier.
18 cl, 11 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POLYMER CARRIER OF DRUG PREPARATIONS FOR VISUALLY-ASSISSTED DELIVERY | 2008 |
|
RU2477146C2 |
| LIPID BILAYER CARRIER FOR MEDICINAL AND IMAGING AGENTS | 2011 |
|
RU2577291C2 |
| CHELATE AMPHIPHILIC POLYMERS | 2009 |
|
RU2519713C2 |
| ELIMINATION OF INVOLVEMENT OF CONTRAST AGENT CONCENTRATION IN MRT | 2007 |
|
RU2446829C2 |
| CEST SYSTEMS PROVIDING SENSITIVITY NOT DEPENDING ON CONCENTRATION | 2011 |
|
RU2605823C2 |
| CARRIERS FOR MPV-REGULATED DELIVERY OF MEDICATION, SENSITIVE TO STIMULATING FACTOR | 2010 |
|
RU2561035C2 |
| MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | 2006 |
|
RU2425831C2 |
| CARRIER FOR DIAGNOSING, DIRECTED DELIVERY AND CONTROLLED RELEASE OF MEDICINAL AGENTS | 2018 |
|
RU2693485C1 |
| APPLICATION OF 1,3-BIS(PERFLUORO-TERT-BUTYL)PROPANE AS A CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING ON F NUCLEI | 2022 |
|
RU2785791C1 |
| MAGNETIC RESONANCE (MR) | 2013 |
|
RU2605516C2 |
